<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230823059233N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-01</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Study of Effects of Group CFT on Social Isolation and Depression in Patients with Multiple Sclerosis</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the Effect of A Group Compassion-based Program on Social Isolation and Depression of Family Caregivers of Patients with Multiple Sclerosis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-12-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73412</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Using the online method of randomization, participants will be randomly assigned into intervention or control groups by the online random number calculator of the GraphPad® website; the procedure consists of the assignment of a random number - from 1 to 60 - to each participant, and then the online calculator will assign the numbers into two equal groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Multiple Sclerosis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention is an in-person educational program of six 120-minutes sessions based on Gilbert's CFT protocol. The participants of intervention group will be divides into three equal groups of ten participants, with each group receiving six in-person 120-minutes group CFT sessions weekly held in the classrooms of selected centers. The first session consists of preliminary communication with and introduction to caregivers, a review of educational program, and introduction to general principles of compassion. Second session teaches mindfulness, breathworks, and body scan basics, ending with a scheduled exercise for next week for participants. The third session introduces the participants to the attributes of a compassionate person. The fourth session focuses on the compassion skills (including compassionate reasoning, attention, feeling, sensations, imagery, and behavior). The fifth session teaches participants the readiness and acceptance of future events. The sixth (and final) session teaches how to write compassionate letters and concludes with a review of previous sections. The certified researcher will be the holder of all sessions under the supervision of the advisor of the study. The content of each session will be presented through face-to-face education using PowerPoint slides and educational pamphlets designed by the researcher. At the end of each session, the participants will receive at-home exercises. The researcher will observe the practice of exercises by caregivers at the same session. The repeated practice will be encourages, and the caregivers will be asked to verbally report about their practices in the next session. The caregivers will be given the phone number of the researcher in case of any question or issue. Intervention 2: Control group: The control group will receive no intervention. In accordance to ethical and professional principles if the effectiveness of the educational program is confirmed, the control group will have access to the recorded educational content.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No further information available</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hojatollah Yousefi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezarjarib</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 913 302 2900</telephone>
        <email>yousefi@nm.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hojatollah Yousefi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezarjarib</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8431919795</zip>
        <telephone>+98 913 302 2900</telephone>
        <email>yousefi@nm.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>A minimum age of 18 and maximum age of 70 years old for the caregivers
Minimum level of literacy needed for reading and writing for the caregivers
Caregivers' consent to participate in study
If the patient has more than one caregiver, the caregiver who spends more time with the patient than others
The physical ability of caregivers to participate in the in-person educational program for at least two hours
The mental capacity of caregivers to participate in the educational program without a self-reported learning or memory disorder
Expanded disability status scale ranging from 2 to 9.5 for patients
Diagnosed with Multiple Sclerosis for at least six months</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Self-reported history of depression or any other disease affecting social interactions for caregivers
Being the caregiver of more than a single person for caregivers
History of other chronic diseases for patients</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G35</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Multiple sclerosis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention is an in-person educational program of six 120-minutes sessions based on Gilbert's CFT protocol. The participants of intervention group will be divides into three equal groups of ten participants, with each group receiving six in-person 120-minutes group CFT sessions weekly held in the classrooms of selected centers. The first session consists of preliminary communication with and introduction to caregivers, a review of educational program, and introduction to general principles of compassion. Second session teaches mindfulness, breathworks, and body scan basics, ending with a scheduled exercise for next week for participants. The third session introduces the participants to the attributes of a compassionate person. The fourth session focuses on the compassion skills (including compassionate reasoning, attention, feeling, sensations, imagery, and behavior). The fifth session teaches participants the readiness and acceptance of future events. The sixth (and final) session teaches how to write compassionate letters and concludes with a review of previous sections. The certified researcher will be the holder of all sessions under the supervision of the advisor of the study. The content of each session will be presented through face-to-face education using PowerPoint slides and educational pamphlets designed by the researcher. At the end of each session, the participants will receive at-home exercises. The researcher will observe the practice of exercises by caregivers at the same session. The repeated practice will be encourages, and the caregivers will be asked to verbally report about their practices in the next session. The caregivers will be given the phone number of the researcher in case of any question or issue.</i_keyword>
      <i_keyword>Control group: The control group will receive no intervention. In accordance to ethical and professional principles if the effectiveness of the educational program is confirmed, the control group will have access to the recorded educational content.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression. Timepoint: Before intervention, immediately after the intervention, and two months after the intervention. Method of measurement: Beck Depression Inventory II.</prim_outcome>
      <prim_outcome>Social isolation. Timepoint: Before intervention, immediately after the intervention, and two months after the intervention. Method of measurement: Russell's UCLA Loneliness Scale questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-28</approval_date>
        <contact_name>Research Ethics Committees of Nursing, Rehabilitation and Management schools- Isfahan University of </contact_name>
        <contact_address>Hezar Jarib Ave., Isfahan City Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
